Journal articleAm J Clin Oncol2013
A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.
- Journal
- Am J Clin Oncol
- Published
- 1 April 2013
- Citations
- 78
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 3
- Its registry lists this paper as resultsAbraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy NCT00691054↗
- BackgroundTAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma NCT04923529↗
- Background1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma NCT04098081↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.